BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33143710)

  • 1. Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus.
    Algorri M; Wong-Beringer A
    Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):50. PubMed ID: 33143710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation.
    Hattar K; Grandel U; Moeller A; Fink L; Iglhaut J; Hartung T; Morath S; Seeger W; Grimminger F; Sibelius U
    Crit Care Med; 2006 Mar; 34(3):835-41. PubMed ID: 16521278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus.
    Hutton MA; Sundaram A; Perri MB; Zervos MJ; Herc ES
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115126. PubMed ID: 32861155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.
    Ohsawa H; Baba T; Enami J; Hiramatsu K
    J Infect Chemother; 2020 May; 26(5):520-522. PubMed ID: 32001173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactam antibiotic-induced release of lipoteichoic acid from Staphylococcus aureus leads to activation of neutrophil granulocytes.
    Lotz S; Starke A; Ziemann C; Morath S; Hartung T; Solbach W; Laskay T
    Ann Clin Microbiol Antimicrob; 2006 Jun; 5():15. PubMed ID: 16803618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tet38 of Staphylococcus aureus Binds to Host Cell Receptor Complex CD36-Toll-Like Receptor 2 and Protects from Teichoic Acid Synthesis Inhibitors Tunicamycin and Congo Red.
    Truong-Bolduc QC; Wang Y; Hooper DC
    Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
    da Costa TM; Cuba GT; Morgado PGM; Nicolau DP; Nouér SA; Dos Santos KRN; Kiffer CRV
    BMC Infect Dis; 2020 Jan; 20(1):74. PubMed ID: 31973753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muramyl dipeptide synergizes with Staphylococcus aureus lipoteichoic acid to recruit neutrophils in the mammary gland and to stimulate mammary epithelial cells.
    Bougarn S; Cunha P; Harmache A; Fromageau A; Gilbert FB; Rainard P
    Clin Vaccine Immunol; 2010 Nov; 17(11):1797-809. PubMed ID: 20826612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable Release of Lipoteichoic Acid From
    Algorri M; Jorth P; Wong-Beringer A
    Front Microbiol; 2020; 11():609280. PubMed ID: 33519759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triton X-100-induced lipoteichoic acid release is correlated with the methicillin resistance in Staphylococcus aureus.
    Ohta K; Komatsuzawa H; Sugai M; Suginaka H
    FEMS Microbiol Lett; 2000 Jan; 182(1):77-9. PubMed ID: 10612735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.
    Cristinacce A; Wright JG; Macpherson M; Iaconis J; Das S
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115292. PubMed ID: 33360809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.
    Laganas V; Alder J; Silverman JA
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2682-4. PubMed ID: 12878541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGN and LTA from
    Wu Y; Chen J; Sun Y; Dong X; Wang Z; Chen J; Dong G
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283626
    [No Abstract]   [Full Text] [Related]  

  • 14. Inactivation of the Monofunctional Peptidoglycan Glycosyltransferase SgtB Allows
    Karinou E; Schuster CF; Pazos M; Vollmer W; Gründling A
    J Bacteriol; 2019 Jan; 201(1):. PubMed ID: 30322854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
    Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
    J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus Lipoteichoic Acid Damages the Skin Barrier through an IL-1-Mediated Pathway.
    Brauweiler AM; Goleva E; Leung DYM
    J Invest Dermatol; 2019 Aug; 139(8):1753-1761.e4. PubMed ID: 30779913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics Differentially Modulate Lipoteichoic Acid-Mediated Host Immune Response.
    Algorri M; Wong-Beringer A
    Antibiotics (Basel); 2020 Sep; 9(9):. PubMed ID: 32899240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2.
    Lotz S; Aga E; Wilde I; van Zandbergen G; Hartung T; Solbach W; Laskay T
    J Leukoc Biol; 2004 Mar; 75(3):467-77. PubMed ID: 14673018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities.
    van Langevelde P; van Dissel JT; Ravensbergen E; Appelmelk BJ; Schrijver IA; Groeneveld PH
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3073-8. PubMed ID: 9835493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.